Advertisement
News > All
Total search results: 6620 | Ordered by Date (descending)
1 2 3 ... 65 66 67
Source
Date
Kiadis Pharma N.V.. (1/4/19). "Press Release: Kiadis Pharma Expands Presence in the United States". Amsterdam & Boston, MA.
2019-01-04
Biogen Inc.. (1/4/19). "Press Release: Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets". Cambridge, MA & Waltham, MA.
2019-01-04
C4 Therapeutics, Inc.. (1/4/19). "Press Release: Roche Degrader-based Medicines Collaboration. C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche". Watertown, MA.
2019-01-04
Rentschler Biopharma SE. (1/3/19). "Press Release: Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site". Laupheim & Milford, MA.
2019-01-03
UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY.
2019-01-03
Bristol-Myers Squibb Company. (1/3/19). "Press Release: Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company". New York, NY & Summit, NJ.
2019-01-03
ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin.
2019-01-03
Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen.
2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim.
2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA.
2019-01-03
Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich.
2019-01-03
Verily Life Sciences. (1/3/19). "Press Release: Verily Announces $1 Billion Investment Round to Fund Growth and Innovation". South San Francisco, CA.
2019-01-03
InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY.
2019-01-03
ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne.
2019-01-03
Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent.
2019-01-03
Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna.
2019-01-02
Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA.
2019-01-02
OBN (UK) Ltd.. (1/2/19). "Press Release: OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise". Abingdon.
2019-01-02
MyoKardia, Inc.. (1/2/19). "Press Release: MyoKardia Regains Global Rights to Mavacamten and MYK-491 Programs from Sanofi". South San Francisco, CA.
2019-01-02
Promethera Biosciences S.A.. (1/2/19). "Press Release: Promethera Biosciences Announces Investment by Itochu Corporation and a Broad Strategic Collaboration to Access the Asian Markets". Mont-Saint-Guibert & Tokyo.
2019-01-02
1 2 3 ...
65 66 67
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top